[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cancer Immunotherapy Market size & share revenue was valued at approximately USD 156.8 Billion in 2023 and is expected to reach USD 168.1 Billion in 2024 and is expected to reach around USD 314.4 Billion by 2033, at a CAGR of 7.2% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are Roche Holding AG, Merck & Co. Inc., Bristol Myers Squibb Company, AstraZeneca plc, Johnson & Johnson, Novartis International AG, Pfizer Inc., Amgen Inc., Eli Lilly and Company, Gilead Sciences Inc., Sanofi, Regeneron Pharmaceuticals Inc., Seattle Genetics Inc., Genentech Inc., Celgene Corporation, and others.
Austin, TX, USA, March 29, 2024 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “Cancer Immunotherapy Market Size, Trends and Insights By Type of Immunotherapy (Monoclonal Antibodies (mAbs), Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Transfer (ACT), Cytokine Therapy), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Leukemia/Lymphoma, Others), By Mode of Administration (Oral, Intravenous (IV), Subcutaneous, Intramuscular, Others), By End-Users (Hospitals, Cancer Research Institutes, Clinics, Ambulatory Surgical Centers (ASCs), Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033” in its research database.
“According to the latest research study, the demand of global Cancer Immunotherapy Market size & share was valued at approximately USD 156.8 Billion in 2023 and is expected to reach USD 168.1 Billion in 2024 and is expected to reach a value of around USD 314.4 Billion by 2033, at a compound annual growth rate (CAGR) of about 7.2% during the forecast period 2024 to 2033.”
Click Here to Access a Free Sample Report of the Global Cancer Immunotherapy Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=43173
Cancer Immunotherapy Market: Growth Factors and Dynamics
- Increasing Prevalence of Cancer: The rising incidence of various types of cancer globally is a significant growth factor for the cancer immunotherapy market. As the prevalence of cancer continues to increase, there is a growing need for effective and targeted treatment options, driving the demand for immunotherapies.
- Advancements in Research and Technology: Ongoing research and technological advancements in the field of cancer immunotherapy have led to the development of novel and more efficient therapies. Breakthroughs in understanding the immune system’s role in cancer defense have resulted in the discovery of new targets and treatment modalities, fostering the market growth.
- Efficacy and Reduced Side Effects: Immunotherapies often offer improved efficacy compared to traditional cancer treatments, and they are known for causing fewer severe side effects. This has increased patient acceptance and contributed to the growing adoption of immunotherapies as a preferred option in cancer treatment regimens.
- Rise in Investment and Funding: The cancer immunotherapy market has witnessed increased investments and funding from both the public and private sectors. Pharmaceutical companies, biotechnology firms, and research institutions are heavily investing in the development of innovative immunotherapies, driving the market’s growth.
- Expanding Approvals and Indications: Regulatory agencies around the world are granting approvals for new immunotherapeutic drugs and expanding their indications. This has broadened the scope of immunotherapy applications across different cancer types, providing healthcare providers with more options for personalized and targeted treatment strategies.
- Patient Awareness and Demand: Growing awareness among patients regarding the benefits of immunotherapy, coupled with increased access to information through various channels, has led to a higher demand for these treatments. Patients and healthcare professionals are increasingly recognizing the potential of immunotherapy in improving outcomes and survival rates, contributing to market dynamics.
- Collaborations and Partnerships: The cancer immunotherapy market has witnessed a surge in collaborations and partnerships between pharmaceutical companies, biotech firms, and academic institutions. These alliances facilitate the pooling of resources, expertise, and technologies, accelerating the development and commercialization of innovative immunotherapies.
Request a Customized Copy of the Cancer Immunotherapy Market Report @ https://www.custommarketinsights.com/inquire-for-discount/?reportid=43173
Cancer Immunotherapy Market: Partnership and Acquisitions
- In 2023, AstraZeneca obtained European Union approval for the tablet formulation of Calquence (acalabrutinib) to treat Chronic Lymphocytic Leukaemia (CLL) in adults. This regulatory approval strengthens AstraZeneca’s market position, expanding treatment options and supporting revenue growth in the field of CLL therapy for adult patients.
- In 2023, The FDA approved Merck’s anti-PD-1 therapy, KEYTRUDA, for neoadjuvant and adjuvant treatment in patients with resectable non-small cell lung cancer (NSCLC). This signifies KEYTRUDA’s role in enhancing surgical outcomes by addressing NSCLC at different stages, providing an advanced treatment option for eligible patients undergoing surgery.
- In 2022, The FDA approved Takeda’s FRUZAQLA (fruquintinib) for the treatment of Previously Treated Metastatic Colorectal Cancer. This marks a significant milestone, offering an additional therapeutic option for patients with advanced colorectal cancer who have undergone prior treatments.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 168.1 Billion |
| Projected Market Size in 2033 | USD 314.4 Billion |
| Market Size in 2023 | USD 156.8 Billion |
| CAGR Growth Rate | 7.2% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type of Immunotherapy, Cancer Type, Mode of Administration, End-Users and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
(A free sample of the Cancer Immunotherapy report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package.
- About 220+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on the Request.
- Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated.
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Custom Market Insights (CMI) research methodology
(Please note that the sample of the Cancer Immunotherapy report has been modified to include the COVID-19 impact study prior to delivery.)
Request a Customized Copy of the Cancer Immunotherapy Market Report @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
Cancer Immunotherapy Market: COVID-19 Analysis
The COVID-19 pandemic has had a significant impact on the Cancer Immunotherapy Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:
- Treatment Disruptions and Delayed Initiations: The COVID-19 pandemic led to disruptions in healthcare services, including cancer diagnosis and treatment. Many cancer patients experienced delays in immunotherapy initiation or interruptions in their treatment schedules due to lockdowns, resource reallocation, and concerns about virus exposure in healthcare settings.
- Supply Chain Disruptions and Clinical Trials Challenges: The pandemic disrupted global supply chains, affecting the availability of drugs and components needed for cancer immunotherapy. Clinical trials for new immunotherapies faced challenges, with delays in patient recruitment, monitoring, and data collection, impacting the overall research and development timeline.
- Resumption of Regular Healthcare Services: As healthcare systems adapted to the pandemic, there has been a gradual resumption of regular services, including cancer screenings, diagnosis, and treatment. This has allowed cancer immunotherapy treatments to regain momentum.
- Emphasis on Telemedicine and Remote Monitoring: The adoption of telemedicine and remote monitoring tools increased during the pandemic, providing healthcare professionals with alternative means to monitor and support cancer patients. This has facilitated continued patient care while minimizing in-person visits, ensuring the safety of both patients and healthcare providers.
- Accelerated Regulatory Approvals: Regulatory agencies have implemented measures to expedite the review and approval of essential medications, including cancer immunotherapies. Fast-track designations and emergency use authorizations have helped bring new therapies to market more quickly, addressing treatment gaps.
- Increased Investment in Research and Development: The recognition of the importance of immunotherapy in cancer treatment has led to increased investment in research and development. Pharmaceutical companies and research institutions are intensifying efforts to innovate and bring new immunotherapies to market, driven by the lessons learned from the pandemic.
In conclusion, the COVID-19 pandemic has had a mixed impact on the Cancer Immunotherapy Market, with some challenges and opportunities arising from the pandemic.
Request a Customized Copy of the Cancer Immunotherapy Market Report @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
Key questions answered in this report:
- What is the size of the Cancer Immunotherapy market and what is its expected growth rate?
- What are the primary driving factors that push the Cancer Immunotherapy market forward?
- What are the Cancer Immunotherapy Industry’s top companies?
- What are the different categories that the Cancer Immunotherapy Market caters to?
- What will be the fastest-growing segment or region?
- In the value chain, what role do essential players play?
- What is the procedure for getting a free copy of the Cancer Immunotherapy market sample report and company profiles?
Key Offerings:
- Market Share, Size & Forecast by Revenue | 2023−2032
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
- Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Buy this Premium Cancer Immunotherapy Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
Cancer Immunotherapy Market – Regional Analysis
The Cancer Immunotherapy Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
- North America: In North America, the Cancer Immunotherapy Market trend involves a robust focus on precision medicine. The region sees increased investments in personalized and targeted immunotherapies, leveraging genomics and biomarkers. Collaborations between academic institutions, pharmaceutical companies, and research centers drive innovation and propel North America as a leader in cancer immunotherapy research and development.
- Europe: Europe’s Cancer Immunotherapy Market trend is characterized by a growing emphasis on real-world evidence (RWE) and value-based healthcare. The region focuses on generating data on the effectiveness and cost-effectiveness of immunotherapies in routine clinical practice, influencing treatment decisions, reimbursement strategies, and healthcare policies.
- Asia-Pacific: The Asia-Pacific Cancer Immunotherapy Market trend centers around expanding access and affordability. Initiatives aim to increase immunotherapy availability to a broader population, addressing healthcare disparities. Collaborations between local and international players, coupled with regulatory support, drive the adoption of immunotherapies across diverse healthcare systems in the region.
- LAMEA (Latin America, Middle East, and Africa): In LAMEA, the Cancer Immunotherapy Market trend involves a growing focus on capacity building and infrastructure development. Efforts are directed toward strengthening healthcare systems, fostering research capabilities, and enhancing the availability of immunotherapies. Partnerships with global organizations support technology transfer and skill development, contributing to the region’s integration into the global immunotherapy landscape.
Request a Customized Copy of the Cancer Immunotherapy Market Report @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
(We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)
Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media?
Email Directly Here with Detail Information: support@custommarketinsights.com
Browse the full “Cancer Immunotherapy Market Size, Trends and Insights By Type of Immunotherapy (Monoclonal Antibodies (mAbs), Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Transfer (ACT), Cytokine Therapy), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Leukemia/Lymphoma, Others), By Mode of Administration (Oral, Intravenous (IV), Subcutaneous, Intramuscular, Others), By End-Users (Hospitals, Cancer Research Institutes, Clinics, Ambulatory Surgical Centers (ASCs), Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033” Report at https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
List of the prominent players in the Cancer Immunotherapy Market:
- Roche Holding AG
- Merck & Co. Inc.
- Bristol Myers Squibb Company
- AstraZeneca plc
- Johnson & Johnson
- Novartis International AG
- Pfizer Inc.
- Amgen Inc.
- Eli Lilly and Company
- Gilead Sciences Inc.
- Sanofi
- Regeneron Pharmaceuticals Inc.
- Seattle Genetics Inc.
- Genentech Inc.
- Celgene Corporation
- Others
Click Here to Access a Free Sample Report of the Global Cancer Immunotherapy Market @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
Spectacular Deals
- Comprehensive coverage
- Maximum number of market tables and figures
- The subscription-based option is offered.
- Best price guarantee
- Free 35% or 60 hours of customization.
- Free post-sale service assistance.
- 25% discount on your next purchase.
- Service guarantees are available.
- Personalized market brief by author.
Browse More Related Reports:
Cancer Monoclonal Antibodies Market: Cancer Monoclonal Antibodies Market Size, Trends and Insights By Type (Humanized, Human, Chimeric, Murine), By Application (Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Others), By Monoclonal Antibody Therapies (Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), Other Monoclonal Antibody Therapies), By End-User (Hospitals, Research Institutes, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Liver Cancer Diagnostics Market: Liver Cancer Diagnostics Market Size, Trends and Insights By Test Type (AFP Tests, LFTs, Biopsy, Others), By End-User (Hospital-associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Anal Cancer Market: Anal Cancer Market Size, Trends and Insights By Drug Type (Fluorouracil, Cisplatin, Carboplatin, Others), By Cancer Type (Carcinoma In-situ, Squamous Cell Carcinoma, Melanoma, Adenocarcinoma, Basal Cell Carcinoma), By Treatment Type (Chemotherapy, Surgery, Radiation Therapy, Immunotherapy), By Distribution Channel (Hospitals & Clinics, Research & Academic Institutes, Long-term Care Centers, Pharmacies), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Lung Cancer Surgery Market: Lung Cancer Surgery Market Size, Trends and Insights By Product (Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assisted Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments), By Application (Lobectomy, Segmentectomy, Wedge Resection, Pneumonectomy), By End-User (Hospitals, Ambulatory Surgical Centers), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Lung Cancer Screening Software Market: Lung Cancer Screening Software Market Size, Trends and Insights By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions, Web Based Solutions), By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACS, Practice Management, Audit Log Tracking), By Type (Computer-Assisted Screening, Traditional Screening), By Application (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), By Platform (Standalone, Integrated), By Purchase Mode (Institutional, Individual), By End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers, Others), By Distribution Channel (Direct Tender, Third Party Distributors), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Breast Cancer Detection Market: Breast Cancer Detection Market Size, Trends and Insights By Technology (Traditional imaging, Advanced imaging, AI-powered diagnostics, Liquid biopsy), By Application (Screening, Diagnosis, Prognosis), By End-Use (Hospitals & Clinics, Diagnostic imaging centers, Breast care centers, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
The Cancer Immunotherapy Market is segmented as follows:
By Type of Immunotherapy
- Monoclonal Antibodies (mAbs)
- Checkpoint Inhibitors
- Cancer Vaccines
- Adoptive Cell Transfer (ACT)
- Cytokine Therapy
By Cancer Type
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Leukemia/Lymphoma
- Others
By Mode of Administration
- Oral
- Intravenous (IV)
- Subcutaneous
- Intramuscular
- Others
By End-Users
- Hospitals
- Cancer Research Institutes
- Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Click Here to Get a Free Sample Report of the Global Cancer Immunotherapy Market @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
This Cancer Immunotherapy Market Research/Analysis Report Contains Answers to the following Questions.
- Which Trends Are Causing These Developments?
- Who Are the Global Key Players in This Cancer Immunotherapy Market? What are Their Company Profile, Product Information, and Contact Information?
- What Was the Global Market Status of the Cancer Immunotherapy Market? What Was the Capacity, Production Value, Cost and PROFIT of the Cancer Immunotherapy Market?
- What Is the Current Market Status of the Cancer Immunotherapy Industry? What’s Market Competition in This Industry, Both Company and Country Wise? What’s Market Analysis of Cancer Immunotherapy Market by Considering Applications and Types?
- What Are Projections of the Global Cancer Immunotherapy Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports?
- What Is Cancer Immunotherapy Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
- What Is the Economic Impact On Cancer Immunotherapy Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
- What Are Market Dynamics of Cancer Immunotherapy Market? What Are Challenges and Opportunities?
- What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Cancer Immunotherapy Industry?
Click Here to Access a Free Sample Report of the Global Cancer Immunotherapy Market @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
Reasons to Purchase Cancer Immunotherapy Market Report
- Cancer Immunotherapy Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
- Cancer Immunotherapy Market report outlines market value (USD) data for each segment and sub-segment.
- This report indicates the region and segment expected to witness the fastest growth and dominate the market.
- Cancer Immunotherapy Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region.
- The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
- Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
- The Industry’s current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
- Cancer Immunotherapy Market Includes in-depth market analysis from various perspectives through Porter’s five forces analysis and provides insight into the market through Value Chain.
Reasons for the Research Report
- The study provides a thorough overview of the global Cancer Immunotherapy market. Compare your performance to that of the market as a whole.
- Aim to maintain competitiveness while innovations from established key players fuel market growth.
Buy this Premium Cancer Immunotherapy Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
What does the report include?
- Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Cancer Immunotherapy market analysis.
- The competitive environment of current and potential participants in the Cancer Immunotherapy market is covered in the report, as well as those companies’ strategic product development ambitions.
- According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions.
- For each segment mentioned above, actual market sizes and forecasts have been given.
Who should buy this report?
- Participants and stakeholders worldwide Cancer Immunotherapy market should find this report useful. The research will be useful to all market participants in the Cancer Immunotherapy industry.
- Managers in the Cancer Immunotherapy sector are interested in publishing up-to-date and projected data about the worldwide Cancer Immunotherapy market.
- Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Cancer Immunotherapy products’ market trends.
- Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans.
Request a Customized Copy of the Cancer Immunotherapy Market Report @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
About Custom Market Insights:
Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.
CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.
Follow Us: LinkedIn | Twitter | Facebook | YouTube
Contact Us:
Joel John
CMI Consulting LLC
1333, 701 Tillery Street Unit 12,
Austin, TX, Travis, US, 78702
USA: +1 801-639-9061
India: +91 20 46022736
Email: support@custommarketinsights.com
Web: https://www.custommarketinsights.com/
Blog: https://www.techyounme.com/
Blog: https://atozresearch.com/
Blog: https://www.technowalla.com/
Blog: https://marketresearchtrade.com/
Buy this Premium Cancer Immunotherapy Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/cancer-immunotherapy-market/
- Camfil USA Provides Strategic Framework for Effective Air Filter Procurement - May 9, 2025
- TGS Successfully Commenced an Active North Europe Summer Season - May 9, 2025
- VGP Trading Update - May 9, 2025
